For the week, the Dow Jones Industrial Average
gained over 1,200 points to 25,538 while the S&P 500 rose 4.8% to 2,760. The
Nasdaq Composite jumped the highest on a percentage basis for the week as Tech
stocks caught a bit of relief. It rose over 5.6% to 7,330.
In ETFs, Emerging markets and Treasuries saw
some of the greatest inflows in the month of November, according to our ETFG
Fund Flow summary. One of the ETFs that took in the biggest flows was IEMG, the iShares Core
MSCI Emerging Market ETF. In the month of November, IEMG took in over $3.24B or
about 8% of its AUM. SHY,
which is iShares 1-3 year Treasury Bond ETF, has followed suit with inflows of
over $1.8B, or about 17% of its AUM.
In the ETFG Quant Movers, we saw sector based ETPs
gain the most percentage points to their overall scores. The Invesco Dynamic
Pharmaceutical ETF (PJP)
and iShares Global Telecom ETF (IXP) added 11.15% and
11.00% to their overall Quant scores respectively.
In the loser’s column, we saw emerging markets
ETPs dropping some percentage points to their overall score. The iShares MSCI
Emerging Markets Asia ETF (EEMA),
Invesco Emerging Markets Infrastructure ETF (PXR) and the iShares Edge
MSCI Min Vol Emerging Markets ETF (EEMV)lost 10.63%, 9.59%
and 9.24% to their overall scores respectively.
ETFG Weekly Select List -
the 5 most highly rated ETFs per Sector, Geographic Region and Strategy as
ranked by the ETFG Quant model.
Because of the sector’s success in the major
indexes this week, we’d like to highlight some substantial movement in the
Global portion when comparing this week’s Select List to last. The iShares
Global Healthcare ETF (IXJ)
jumped up two spots to be the top ranked fund in the sector. It took over for
the iShares Global Consumer Staples ETF (KXI) which is now in the 3rd
ranked spot. The iShares Global 100 ETF (IOO) held steady at the 2nd
spot for two consecutive weeks while the VanEck Vectors Biotech ETF (BBH) moved into the 5th
spot knocking the Invesco Shipping ETF (SEA) off the list.
Thanks for reading ETF Global Perspectives
ETFG 21 Day Free Trial: https://www.etfg.com/signup/quick
______________________________________________________
Assumptions,
opinions and estimates constitute our judgment as of the date of this material
and are subject to change without notice.
ETF Global LLC (“ETFG”) and its affiliates and any third-party
providers, as well as their directors, officers, shareholders, employees or
agents (collectively ETFG Parties) do not guarantee the accuracy, completeness,
adequacy or timeliness of any information, including ratings and rankings and
are not responsible for errors and omissions or for the results obtained from the
use of such information and ETFG Parties shall have no liability for any
errors, omissions, or interruptions therein, regardless of the cause, or for
the results obtained from the use of such information. ETFG PARTIES DISCLAIM
ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY
WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE
OR USE. In no event shall ETFG Parties
be liable to any party for any direct, indirect, incidental, exemplary,
compensatory, punitive, special or consequential damages, costs, expenses,
legal fees, or losses (including, without limitation, lost income or lost
profits and opportunity costs) in connection with any use of the information
contained in this document even if advised of the possibility of such damages.
ETFG
ratings and rankings are statements of opinion as of the date they are
expressed and not statements of fact or recommendations to purchase, hold, or
sell any securities or to make any investment decisions. ETFG ratings and
rankings should not be relied on when making any investment or other business
decision. ETFG’s opinions and analyses
do not address the suitability of any security.
ETFG does not act as a fiduciary or an investment advisor. While ETFG has obtained information from
sources they believe to be reliable, ETFG does not perform an audit or
undertake any duty of due diligence or independent verification of any
information it receives.
This
material is not intended as an offer or solicitation for the purchase or sale
of any security or other financial instrument. Securities, financial
instruments or strategies mentioned herein may not be suitable for all
investors. Any opinions expressed herein
are given in good faith, are subject to change without notice, and are only
correct as of the stated date of their issue.
Prices, values, or income from any securities or investments mentioned
in this report may fall against the interests of the investor and the investor
may get back less than the amount invested.
Where an investment is described as being likely to yield income, please
note that the amount of income that the investor will receive from such an
investment may fluctuate. Where an
investment or security is denominated in a different currency to the investor's
currency of reference, changes in rates of exchange may have an adverse effect
on the value, price or income of or from that investment to the investor.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.